Skip to main content
Top
Published in: Radiation Oncology 1/2015

Open Access 01-12-2015 | Research

Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution

Authors: Christiane Matuschek, Thomas A Ochtrop, Edwin Bölke, Ute Ganswindt, Roland Fenk, Stephan Gripp, Patric Kröpil, Peter Arne Gerber, Kai Kammers, Jackson Hamilton, Klaus Orth, Wilfried Budach

Published in: Radiation Oncology | Issue 1/2015

Login to get access

Abstract

Background

Palliative irradiation of osteolytic lesions is a considerable component in the treatment for patients with multiple myeloma. In this study, we analyzed the efficacy of irradiation in these patients.

Patients and methods

We retrospectively analyzed 153 patients with multiple myeloma who were admitted to our department between 1989 and 2013. According to the staging system of Durie & Salmon 116 patients were classified as stage III. 107/153 patients were treated with radiotherapy of at least one and up to 6 bony lesions at different times. In order to evaluate the effect of local radiotherapy on pain relief and bone recalcification a uni- and multivariate analysis was performed using a binary logistic regression model to correct for multiple measurements. Complete information on dose, fractionation and volume of radiotherapy was available from 81 patients treated in 136 target volumes for pain relief, and from 69 patients treated in 108 target volumes for recalcification. Total radiation doses varied between 8 Gy to 50 Gy (median dose 25 Gy in 2.5 Gy fractions, 5 times a week).

Results

Radiotherapy resulted in complete local pain relief in 31% and partial local pain relief in 54% of the patients. In the univariate analysis, higher total radiation doses (p = 0.023) and higher age (p = 0.014) at the time of radiotherapy were significantly associated with a higher likelihood of pain relief, whereas no significant association was detected for concurrent systemic treatment, type and stage of myeloma and location of bone lesions. The same variables were independent predictors for pain relief in the multivariate analysis. Recalcification was observed in 48% of irradiated bone lesions. In the uni- and multivariate analysis higher radiation doses were significantly associated (p = 0.048) with an increased likelihood of recalcification. Side effects of radiotherapy were generally mild.

Conclusions

Higher total biological radiation doses were associated with better pain relief and recalcification in this retrospective evaluation of multiple myeloma patients. In addition, in the elderly the therapeutic measures appear to develop a better analgesic effect.
Literature
1.
go back to reference Usmani SZ, Crowley J, Hoering A, Mitchell A, Waheed S, Nair B, et al. Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? Leukemia. 2013;27:226–32.CrossRefPubMedCentralPubMed Usmani SZ, Crowley J, Hoering A, Mitchell A, Waheed S, Nair B, et al. Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? Leukemia. 2013;27:226–32.CrossRefPubMedCentralPubMed
2.
go back to reference Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol. 2004;48:599–606.CrossRefPubMed Vakaet LA, Boterberg T. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol. 2004;48:599–606.CrossRefPubMed
3.
go back to reference Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, et al. Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood. 2003;102:1927–9.CrossRefPubMed Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I, et al. Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood. 2003;102:1927–9.CrossRefPubMed
4.
go back to reference Balducci M, Chiesa S, Manfrida S, Rossi E, Za T, Frascino V, et al. Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol. 2011;187:114–9.CrossRefPubMed Balducci M, Chiesa S, Manfrida S, Rossi E, Za T, Frascino V, et al. Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol. 2011;187:114–9.CrossRefPubMed
5.
go back to reference Mose S, Pfitzner D, Rahn A, Nierhoff C, Schiemann M, Böttcher HD, et al. Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Onkol. 2000;176:506–12.CrossRefPubMed Mose S, Pfitzner D, Rahn A, Nierhoff C, Schiemann M, Böttcher HD, et al. Role of radiotherapy in the treatment of multiple myeloma. Strahlenther Onkol. 2000;176:506–12.CrossRefPubMed
6.
go back to reference Stolting T, Knauerhase H, Klautke G, Kundt G, Fietkau R. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Strahlenther Onkol. 2008;184:465–72.CrossRefPubMed Stolting T, Knauerhase H, Klautke G, Kundt G, Fietkau R. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma. Strahlenther Onkol. 2008;184:465–72.CrossRefPubMed
7.
go back to reference Adamietz IA, Schober C, Schulte RW, Peest D, Renner K. Palliative radiotherapy in plasma cell myeloma. Radiother Oncol. 1991;20:111–6.CrossRefPubMed Adamietz IA, Schober C, Schulte RW, Peest D, Renner K. Palliative radiotherapy in plasma cell myeloma. Radiother Oncol. 1991;20:111–6.CrossRefPubMed
8.
go back to reference Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer. 2006;42:1539–43.CrossRefPubMed Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer. 2006;42:1539–43.CrossRefPubMed
9.
go back to reference Norman G. Likert scales, levels of measurement and the “laws” of statistics. Adv Health Sci Educ Theory Pract. 2010;15:625–32.CrossRefPubMed Norman G. Likert scales, levels of measurement and the “laws” of statistics. Adv Health Sci Educ Theory Pract. 2010;15:625–32.CrossRefPubMed
10.
go back to reference Jordan K, Sanger S: Empfehlungen zur Bewertung der Tumorremission. In Schmoll, Höffken, Possinger (Editors): Kompendium der internistischen Onkologie. Springer Verlag Heidelberg 2006.4.Aufl.,Band 3:p860-865, (ISBN 10 3-540-20657-4) Jordan K, Sanger S: Empfehlungen zur Bewertung der Tumorremission. In Schmoll, Höffken, Possinger (Editors): Kompendium der internistischen Onkologie. Springer Verlag Heidelberg 2006.4.Aufl.,Band 3:p860-865, (ISBN 10 3-540-20657-4)
11.
go back to reference Wang DC. Presentation of treatment results according to ‘Reporting Results of Cancer Treatment’ recommended by the World Health Organization (WHO), 1981–long term survival of 1,035 cases of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi. 1985;7:58–61.PubMed Wang DC. Presentation of treatment results according to ‘Reporting Results of Cancer Treatment’ recommended by the World Health Organization (WHO), 1981–long term survival of 1,035 cases of nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi. 1985;7:58–61.PubMed
12.
go back to reference Lutje S, De Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009;88:1161–8.CrossRefPubMedCentralPubMed Lutje S, De Rooy JW, Croockewit S, Koedam E, Oyen WJ, Raymakers RA. Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma. Ann Hematol. 2009;88:1161–8.CrossRefPubMedCentralPubMed
13.
go back to reference Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.CrossRefPubMed Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.CrossRefPubMed
14.
go back to reference Herrmann TBM, Dörr W. Klinische Strahlenbiologie. München: Urban & Fischer; 2006. p. 33–6. Herrmann TBM, Dörr W. Klinische Strahlenbiologie. München: Urban & Fischer; 2006. p. 33–6.
15.
go back to reference Perez CA, Brady LW. Principles and Practice of Radioation Oncology (ed 4th reviesed Edition). New York: Lippincott Wiliams & Wilki; 2004. p. 1053–8. Perez CA, Brady LW. Principles and Practice of Radioation Oncology (ed 4th reviesed Edition). New York: Lippincott Wiliams & Wilki; 2004. p. 1053–8.
16.
go back to reference Filippovich IV, Sorokina NI, Robillard N, Lisbona A, Chatal J-F. Radiation-induced apoptosis in human tumor cell lines: adaptive response and split-dose effect. Int J Cancer. 1998;77:76–81.CrossRefPubMed Filippovich IV, Sorokina NI, Robillard N, Lisbona A, Chatal J-F. Radiation-induced apoptosis in human tumor cell lines: adaptive response and split-dose effect. Int J Cancer. 1998;77:76–81.CrossRefPubMed
17.
go back to reference van der Linden YM, Lok JJ, Steenland E, Martijn H, Van Houwelingen H, Marijnen CA, et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004;59:528–37.CrossRefPubMed van der Linden YM, Lok JJ, Steenland E, Martijn H, Van Houwelingen H, Marijnen CA, et al. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment. Int J Radiat Oncol Biol Phys. 2004;59:528–37.CrossRefPubMed
18.
go back to reference Hoskin PJ. Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev. 2003;29:321–7.CrossRefPubMed Hoskin PJ. Bisphosphonates and radiation therapy for palliation of metastatic bone disease. Cancer Treat Rev. 2003;29:321–7.CrossRefPubMed
19.
go back to reference Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol. 1999;175:500–8.CrossRefPubMed Koswig S, Budach V. Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study. Strahlenther Onkol. 1999;175:500–8.CrossRefPubMed
20.
go back to reference Foro Arnalot P, Fontanals AV, Galceran JC, Lynd F, Latiesas XS, De Dios NR, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89:150–5.CrossRefPubMed Foro Arnalot P, Fontanals AV, Galceran JC, Lynd F, Latiesas XS, De Dios NR, et al. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction. Radiother Oncol. 2008;89:150–5.CrossRefPubMed
21.
go back to reference Leigh BR, Kurtts TA, Mack CF, Matzner MB, Shimm DS. Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys. 1993;25:801–4.CrossRefPubMed Leigh BR, Kurtts TA, Mack CF, Matzner MB, Shimm DS. Radiation therapy for the palliation of multiple myeloma. Int J Radiat Oncol Biol Phys. 1993;25:801–4.CrossRefPubMed
22.
go back to reference Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). 2000;14:101–8. 111; discussion 111–2, 115. Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). 2000;14:101–8. 111; discussion 111–2, 115.
23.
go back to reference Dimopoulos MA, Goldstein J, Fuller L, Delasalle K, Alexanian R. Curability of solitary bone plasmacytoma. J Clin Oncol. 1992;10:587–90.PubMed Dimopoulos MA, Goldstein J, Fuller L, Delasalle K, Alexanian R. Curability of solitary bone plasmacytoma. J Clin Oncol. 1992;10:587–90.PubMed
24.
go back to reference Mill WB, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer. 1980;45:647–52.CrossRefPubMed Mill WB, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer. 1980;45:647–52.CrossRefPubMed
25.
go back to reference Bosch A, Frias Z. Radiotherapy in the treatment of multiple myeloma. Int J Radiat Oncol Biol Phys. 1988;15:1363–9.CrossRefPubMed Bosch A, Frias Z. Radiotherapy in the treatment of multiple myeloma. Int J Radiat Oncol Biol Phys. 1988;15:1363–9.CrossRefPubMed
26.
go back to reference Rieden K, Kober B, Mende U, zum Winkel K. Radiotherapy of pathological fractures and skeletal lesions in danger of fractures. Strahlenther Onkol. 1986;162:742–9.PubMed Rieden K, Kober B, Mende U, zum Winkel K. Radiotherapy of pathological fractures and skeletal lesions in danger of fractures. Strahlenther Onkol. 1986;162:742–9.PubMed
27.
go back to reference Weber W, Rosler HP, Doll G, Dostert M, Kutzner J, et al. The percutaneous irradiation of osteolytic bone metastases-a course assessment. Strahlenther Onkol. 1992;168:275–80.PubMed Weber W, Rosler HP, Doll G, Dostert M, Kutzner J, et al. The percutaneous irradiation of osteolytic bone metastases-a course assessment. Strahlenther Onkol. 1992;168:275–80.PubMed
28.
go back to reference Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:1063–7.CrossRefPubMed Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:1063–7.CrossRefPubMed
29.
go back to reference Norin T. Roentgen treatment of myeloma with special consideration to the dosage. Acta Radiol. 1957;47:46–54.CrossRefPubMed Norin T. Roentgen treatment of myeloma with special consideration to the dosage. Acta Radiol. 1957;47:46–54.CrossRefPubMed
Metadata
Title
Effects of Radiotherapy in the treatment of multiple myeloma: a retrospective analysis of a Single Institution
Authors
Christiane Matuschek
Thomas A Ochtrop
Edwin Bölke
Ute Ganswindt
Roland Fenk
Stephan Gripp
Patric Kröpil
Peter Arne Gerber
Kai Kammers
Jackson Hamilton
Klaus Orth
Wilfried Budach
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2015
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-015-0374-z

Other articles of this Issue 1/2015

Radiation Oncology 1/2015 Go to the issue